1,1-Biphenyl-2-yl alkylamines, formulations and antiarrhythmic treatment
申请人:Eli Lilly and Company
公开号:US04277471A1
公开(公告)日:1981-07-07
Biphenylylalkylamines which have anti-arrhythmic activity have been prepared. Pharmaceutical formulations containing such compounds and a method of treating cardiac arrhythmias are provided.